Evidence map›Paper›PMID 41647398›Full record

ArticleRSC advances2026

An integrated strategy based on LC/MS for the systematic screening of loganin metabolites

Ping Wu, Hualian Zhu, Dingli Hu, Yuhua Tan, Sixuan Yang, Yongliang Huang, Kailin Li, Hui Li

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ping WuHospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075 China.
Hualian ZhuHospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075 China.
Dingli HuSchool of Pharmaceutical Sciences, Hunan University of Medicine Huaihua 418000 China 20250941590@bucm.edu.cn lhi18@163.com.
Yuhua TanSchool of Pharmaceutical Sciences, Hunan University of Medicine Huaihua 418000 China 20250941590@bucm.edu.cn lhi18@163.com.
Sixuan YangSchool of Pharmaceutical Sciences, Hunan University of Medicine Huaihua 418000 China 20250941590@bucm.edu.cn lhi18@163.com.
Yongliang HuangHospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075 China.
Kailin LiSchool of Pharmaceutical Sciences, Hunan University of Medicine Huaihua 418000 China 20250941590@bucm.edu.cn lhi18@163.com.ORCID https://orcid.org/0000-0003-1372-8140
Hui LiSchool of Pharmaceutical Sciences, Hunan University of Medicine Huaihua 418000 China 20250941590@bucm.edu.cn lhi18@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loganin is an active compound derived from

Identifiers

PMID41647398
PMCPMC12869546

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.